(Q40011079)

English

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

scientific article published on 10 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

multicenter clinical trial

0 references

chronic inflammatory demyelinating polyradiculoneuropathy

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

RMC Trial Group

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

10 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

158-164

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

129th ENMC International Workshop: Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy, 27th October 2004, Schiphol airport, The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The AMC Linear Disability Score project in a population requiring residential care: psychometric properties

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Academic Medical Center Linear Disability Score (ALDS) item bank: item response theory analysis in a mixed patient population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic relapsing polyneuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970299-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(08)70299-0

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40011079&oldid=1882618172"